Company news
Nexentis Technologies Inc. (NASDAQ:NXTS) news
Nexentis Technologies Inc. news releases on 6ix. Latest, Sep 23, 2026: Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility…
Press releases & updates
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
September 23, 2026
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign
July 28, 2026
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative
July 7, 2026
Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment
June 29, 2026
Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
June 21, 2026
Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
June 17, 2026
Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
May 18, 2026
Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone
May 13, 2026
Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™
May 5, 2026
Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform
March 12, 2026
N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
February 24, 2026
N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake
January 5, 2026
N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy
December 29, 2025
N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
October 22, 2025
N2OFF Regains Compliance with Nasdaq Minimum Bid Price Requirement
October 8, 2025
N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
September 24, 2025
N2OFF Announces Reverse Stock Split
September 18, 2025
N2OFF Provides Business Update on Successful Execution of Solar and Energy Storage Initiatives Across Europe
September 18, 2025
N2OFF to Expand its Melz Solar Project with Battery Storage
September 11, 2025
N2OFF Completes $1.2 million of its $2.7 million Total Commitment to Finance 196MWp Battery Energy Storage Assets in Italy
July 11, 2025
N2OFF is Increasing its Investment in Melz Project to Explore Additional 40-60 MW Battery Storage
June 16, 2025
N2OFF Energy Targets European’s Energy Crises with Fourth Regional Battery Project
May 15, 2025
N2OFF via Solterra Expands European Footprint with Entry into Fourth Project – a Battery Storage Venture in Poland
May 9, 2025
N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany
April 8, 2025
N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects
March 18, 2025
N2OFF Secures Definitive Agreement to Commercialize 196 MWp Battery Storage Projects
March 5, 2025
N2OFF Establishes a US Subsidiary for Its Solar PV Operations
March 3, 2025
N2OFF and Solterra Announce the Closing of a Definitive Agreement to Develop 196 MWp Battery Storage Projects in Italy
February 23, 2025
NTWO OFF Achieved Positive Results of Over 22% improvement in Reduction of N2O Emissions in Open Greenhouse Environment
May 8, 2024